Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2015
∙
NACI
Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule
2015
∙
SAGE
What is the effectiveness of inactivated Vero cell-derived JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
2015
∙
SAGE
What is the effectiveness of live attenuated JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
2015
∙
SAGE
What is the effectiveness of live recombinant JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
2015
∙
SAGE
What is the risk of serious adverse events following vaccination with inactivated Vero cell-derived JE vaccine?
2015
∙
Emmanuel Bissagnene
1st oridinary session 2015 of the NITAG in the Ivory Coast
2015
∙
WHO
2015 Assessment Report of the Global Vaccine Action Plan
2015
∙
WHO WPRO
24th Meeting of theTechnical Advisory Group on Immunization and Vaccine-Preventable Diseases
2015
∙
Joseph Bocchini Jr
ACIP Japanese Encephalitis (JE) and Yellow Fever (YF) Vaccines Work Group
2015
∙
ACIP
ACIP minutes meeting
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register